ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Calidi Biotherapeutics Inc

Calidi Biotherapeutics Inc (CLDI)

0.8346
-0.0593
(-6.63%)
Closed 22 January 8:00AM
0.8771
0.0425
(5.09%)
After Hours: 11:58AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.8771
Bid
-
Offer
-
Volume
522,038
0.8108 Day's Range 0.9009
0.73 52 Week Range 16.80
Market Cap
Previous Close
0.8939
Open
0.9009
Last Trade
1239
@
0.8346
Last Trade Time
Financial Volume
US$ 441,109
VWAP
0.844975
Average Volume (3m)
1,917,056
Shares Outstanding
13,078,022
Dividend Yield
-
PE Ratio
-0.37
Earnings Per Share (EPS)
-2.23
Revenue
-
Net Profit
-29.22M

About Calidi Biotherapeutics Inc

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index. The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
-
Calidi Biotherapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the American Stock Exchange with ticker CLDI. The last closing price for Calidi Biotherapeutics was US$0.89. Over the last year, Calidi Biotherapeutics shares have traded in a share price range of US$ 0.73 to US$ 16.80.

Calidi Biotherapeutics currently has 13,078,022 shares in issue. The market capitalisation of Calidi Biotherapeutics is US$11.69 million. Calidi Biotherapeutics has a price to earnings ratio (PE ratio) of -0.37.

CLDI Latest News

Calidi Biotherapeutics Announces Presentation of New Data of Systemic Virotherapy RTNova Platform at the AACR Annual Meeting in April 2025

SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted...

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock

SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted...

Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock

SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of...

Calidi Biotherapeutics Announces Proposed Public Offering

SAN DIEGO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of...

Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer

SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted...

Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock

SAN DIEGO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted...

Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock

SAN DIEGO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of...

Calidi Biotherapeutics Announces Proposed Public Offering

SAN DIEGO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of...

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results

Announced FDA Clearance of the Northwestern University IND Application for NeuroNova (CLD-101) Clinical Trial in High-Grade Glioma.Presented data supporting RTNova (CLD-400), the company’s...

Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences

- RTNova, an innovative systemic antitumor enveloped virotherapy, unlocks new possibilities in cancer therapy - RTNova addresses challenges posed by untargetable and untreatable metastatic...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0679-7.185185185190.9450.94710.839409280.90639147CS
4-0.4929-35.97810218981.371.530.81812386401.18166528CS
12-0.2629-23.06140350881.143.890.81819170562.07134073CS
26-1.0129-53.59259259261.893.890.7310159041.93410228CS
52-10.3229-92.1687511.216.80.7311208142.53818993CS
156-44.2229-98.05521064345.1500.738437032.96765243CS
260-44.2229-98.05521064345.1500.738437032.96765243CS

CLDI - Frequently Asked Questions (FAQ)

What is the current Calidi Biotherapeutics share price?
The current share price of Calidi Biotherapeutics is US$ 0.8771
How many Calidi Biotherapeutics shares are in issue?
Calidi Biotherapeutics has 13,078,022 shares in issue
What is the market cap of Calidi Biotherapeutics?
The market capitalisation of Calidi Biotherapeutics is USD 11.69M
What is the 1 year trading range for Calidi Biotherapeutics share price?
Calidi Biotherapeutics has traded in the range of US$ 0.73 to US$ 16.80 during the past year
What is the PE ratio of Calidi Biotherapeutics?
The price to earnings ratio of Calidi Biotherapeutics is -0.37
What is the reporting currency for Calidi Biotherapeutics?
Calidi Biotherapeutics reports financial results in USD
What is the latest annual profit for Calidi Biotherapeutics?
The latest annual profit of Calidi Biotherapeutics is USD -29.22M
What is the registered address of Calidi Biotherapeutics?
The registered address for Calidi Biotherapeutics is CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Calidi Biotherapeutics website address?
The website address for Calidi Biotherapeutics is www.calidibio.com
Which industry sector does Calidi Biotherapeutics operate in?
Calidi Biotherapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TPETTrio Petroleum Corp
US$ 2.64
(48.31%)
45.75M
HUSAHouston American Energy Corp
US$ 2.36
(41.32%)
36.4M
CHROChannel Therapeutics Corporation
US$ 2.6411
(39.01%)
32.13M
EONREON Resources Inc
US$ 1.33
(30.39%)
133.23M
RHERegional Health Properties Inc
US$ 2.84
(24.02%)
250.49k
SCPXScorpius Holdings Inc
US$ 0.301
(-95.93%)
1.08M
ROLRHigh Roller Technologies Inc
US$ 4.77
(-18.98%)
47.13k
AEONAEON Biopharma Inc
US$ 0.129199
(-16.10%)
12M
BWETAmplify Commodity Trust
US$ 10.4273
(-13.23%)
2.25k
ETUT Rex 2X Long Ether Daily Target ETF
US$ 36.63
(-11.80%)
36k
EONREON Resources Inc
US$ 1.33
(30.39%)
133.45M
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 12.685
(-3.39%)
66.6M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 33.69
(3.69%)
60.46M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 5.79
(-2.53%)
52.66M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2.13
(1.43%)
48.58M

CLDI Discussion

View Posts
Monksdream Monksdream 1 month ago
CLDI, under $2
👍️0
glenn1919 glenn1919 2 months ago
CLDI.........................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 2 months ago
CLDI......................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 2 months ago
$3.50 + 70% Pump time next resistance at $3.80 if it got crazy next level in $5s 
👍️0
glenn1919 glenn1919 2 months ago
CLDI....................................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 2 months ago
CLDI.........................................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 3 months ago
CLDI.............................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 3 months ago
Go again lol $1.17 back to .99
Or ready to pump 
👍️0
totffe totffe 3 months ago
Yep, golden opportunity!
👍️0
totffe totffe 3 months ago
LOL, well no one is selling and the stock showed good gains end of week. Very bullish!
👍️0
ErnieBilco ErnieBilco 3 months ago
They were not BUYS but option awards not one of them have exercised their right to buy at $1.09.

It is not bullish at all
👍️0
Monksdream Monksdream 3 months ago
CLDI under $2
👍️0
totffe totffe 3 months ago
Fantastic buying opportunity. 6 company officers filed Form 4's last week, all buys. Bullish
👍️0
Monksdream Monksdream 3 months ago
CLDI new 52 week low
👍️ 1 😎 1
Monksdream Monksdream 5 months ago
CLDI under $2
👍️0
Monksdream Monksdream 5 months ago
CLDI new 52=week low
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
CLDI..NEXT POST SPLIT BUCKAROO!!!!
👍️0
Monksdream Monksdream 6 months ago
CLDI under $2
👍️0
Monksdream Monksdream 6 months ago
CLDI under $2
👍️0
ErnieBilco ErnieBilco 6 months ago
Probably because it is a worthless company that is heavily in debt and by all rights it should be kicked off the Nasdaq but Nasdaq urges these worthless companies to screw their shareholders to artificially get their stock price to $1 - I expect a landslide decline back to a quarter in short order.

This is one of my bets that doesn't look like it will make me any money - unless they can somehow pump it up on the fact the the OS will be about 5 million shares on split day.

Just my take on it after looking thru Q1 Quarterly report.
👍️0
JTORENCE JTORENCE 6 months ago
Ernie Bilco You may have predicted right. Reverse splits are usually the death blow for a stock. Hope not. Why did they do this??
👍️0
Invest-in-America Invest-in-America 7 months ago
CLDI: News --- collaboration with SIGA to kill all Cancers.
👍️0
Termite7 Termite7 8 months ago
Keeping an eye...... coiled!!!
👍️0
accipiterr accipiterr 8 months ago
April 24th webinar
https://redchip.zoom.us/webinar/register/WN_qT-PBRbTQ0yLeBbJ4jzPSw
in this one they mention 3 different times that they are talking to large pharmaceutical companies about licencing and about how the recent data, specifically for RTnova, has resulted in high level discussions with more planned in the near future.


May 9th webinar
https://sidoti.zoom.us/webinar/register/WN_p8GBAbbqTd2OuYnM33eTuQ#/registration
👍️0
accipiterr accipiterr 8 months ago
Bottom in, looks ready for a move up. Data being presented on June 1st.
👍️0
ErnieBilco ErnieBilco 9 months ago
Yikes, RedChip is usually the kiss of death for all the stocks they have pumped or paid promoted
👍️0
Legend431 Legend431 9 months ago
Looking good
👍️0
Triple nickle Triple nickle 9 months ago
Here we gooooo
👍️0
2020trader 2020trader 9 months ago
DOWN 6% TODAY....EXPECTING LOWER
👍️0
glenn1919 glenn1919 11 months ago
CLDI................................................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783
👍️0

Your Recent History

Delayed Upgrade Clock